Glaucoma incidence risk in a cohort of Mayak PA workers occupationally exposed to ionizing radiation.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
28 08 2019
28 08 2019
Historique:
received:
01
10
2018
accepted:
15
08
2019
entrez:
30
8
2019
pubmed:
30
8
2019
medline:
21
10
2020
Statut:
epublish
Résumé
Glaucoma is a major cause of visual impairment, and secondary glaucoma manifested as neovascular glaucoma has long been known to occur following high-dose fractionated radiation therapy. In contrast, little is known as to whether ionizing radiation exposure causes primary glaucoma, except that a single study in Japanese atomic bomb survivors has reported a significantly increase risk. Therefore, the effect of lower dose and lower dose rate remains unclear. Here we report that in Russian Mayak Production Association workers occupationally exposed to chronic radiation for prolonged periods, incidence of total primary glaucoma and primary open-angle glaucoma is significantly associated with various non-radiation factors (sex, attained age, and cataract diagnosed prior to glaucoma), but neither with cumulative dose from external γ-rays nor with cumulative neutron dose nor with the unweighted sum of cumulative γ and neutron doses. The present results suggest for the first time that chronic radiation exposure does not cause primary glaucoma, although the analyses need to be made in other cohorts exposed at various dose and dose rate.
Identifiants
pubmed: 31462740
doi: 10.1038/s41598-019-48915-6
pii: 10.1038/s41598-019-48915-6
pmc: PMC6713741
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
12469Références
Ann ICRP. 2007;37(2-4):1-332
pubmed: 18082557
Ophthalmology. 2002 Oct;109(10):1855-61
pubmed: 12359606
Bull World Health Organ. 1994;72(3):323-6
pubmed: 8062393
J Glaucoma. 2005 Oct;14(5):384-6
pubmed: 16148587
Ophthalmology. 2015 Jan;122(1):72-8
pubmed: 25283061
Radiother Oncol. 2003 May;67(2):199-206
pubmed: 12812851
Radiat Res. 2013 Oct;180(4):422-30
pubmed: 24059679
Ophthalmology. 2008 Jan;115(1):85-93
pubmed: 17629563
Mutat Res. 2019 Jan - Mar;779:36-44
pubmed: 31097150
Mol Vis. 2007 May 14;13:719-23
pubmed: 17563722
Eye (Lond). 2008 Mar;22(3):349-53
pubmed: 17072291
PLoS One. 2016 Oct 10;11(10):e0164357
pubmed: 27723789
Eur J Epidemiol. 2018 Dec;33(12):1193-1204
pubmed: 30306422
Invest Ophthalmol Vis Sci. 2008 Oct;49(10):4453-7
pubmed: 18586872
Am J Ophthalmol. 2007 Jan;143(1):125-130
pubmed: 17188046
Dev Ophthalmol. 2012;49:41-57
pubmed: 22042012
Int J Radiat Oncol Biol Phys. 1999 Jun 1;44(3):599-605
pubmed: 10348290
Int J Radiat Biol. 2004 May;80(5):339-45
pubmed: 15223766
Invest Ophthalmol Vis Sci. 2008 Dec;49(12):5397-402
pubmed: 18719076
Radiat Environ Biophys. 2019 May;58(2):139-149
pubmed: 30879144
Arch Ophthalmol. 2002 Jul;120(7):933-40
pubmed: 12096964
Health Phys. 2013 Apr;104(4):366-78
pubmed: 23439140
Ophthalmology. 2001 Nov;108(11):2116-21
pubmed: 11713089
Korean J Ophthalmol. 2007 Mar;21(1):33-8
pubmed: 17460430
Health Phys. 2008 May;94(5):449-58
pubmed: 18403966
Invest Ophthalmol Vis Sci. 2003 Sep;44(9):3783-9
pubmed: 12939292
Br J Ophthalmol. 2006 Mar;90(3):262-7
pubmed: 16488940
PLoS One. 2017 May 8;12(5):e0176894
pubmed: 28481907
Sci Rep. 2018 Jul 11;8(1):10481
pubmed: 29992993
Ophthalmic Res. 2012;47(4):171-88
pubmed: 22123077
Sci Rep. 2019 Jun 14;9(1):8642
pubmed: 31201344
Radiat Res. 2004 Jun;161(6):622-32
pubmed: 15161358
Eur J Ophthalmol. 2006 Jul-Aug;16(4):637-40
pubmed: 16952111
Oncotarget. 2018 Feb 3;9(16):12932-12940
pubmed: 29560121
Prog Retin Eye Res. 2002 Jul;21(4):359-93
pubmed: 12150988